Instead of BRCA2 itself, this study detected mutations in FPC-CRC kindreds in PALB2, a co-localizer and partner gene to BRCA2, which is also proposed to be involved in FPC [44]. The gene discussed is BRCA2; the disease is colorectal carcinoma.